Fungal Endophthalmitis Associated with Compounded Products
Supporting Files
Public Domain
-
Feb 2014
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Mikosz, Christina A. ; Smith, Rachel M. ; Kim, Moon ; Tyson, Clara ; Lee, Ellen H. ; Adams, Eleanor ; Straif-Bourgeois, Susanne ; Sowadsky, Rick ; Arroyo, Shannon ; Grant-Greene, Yoran ; Duran, Julie ; Vasquez, Yvonne ; Robinson, Byron F. ; Harris, Julie R. ; Lockhart, Shawn R. ; Török, Thomas J. ; Mascola, Laurene ; Park, Benjamin J.
-
Corporate Authors:
-
Description:Fungal endophthalmitis is a rare but serious infection. In March 2012, several cases of probable and laboratory-confirmed fungal endophthalmitis occurring after invasive ocular procedures were reported nationwide. We identified 47 cases in 9 states: 21 patients had been exposed to the intraocular dye Brilliant Blue G (BBG) during retinal surgery, and the other 26 had received an intravitreal injection containing triamcinolone acetonide. Both drugs were produced by Franck's Compounding Lab (Ocala, FL, USA). Fusarium incarnatum-equiseti species complex mold was identified in specimens from BBG-exposed case-patients and an unopened BBG vial. Bipolaris hawaiiensis mold was identified in specimens from triamcinolone-exposed case-patients. Exposure to either product was the only factor associated with case status. Of 40 case-patients for whom data were available, 39 (98%) lost vision. These concurrent outbreaks, associated with 1 compounding pharmacy, resulted in a product recall. Ensuring safety and integrity of compounded medications is critical for preventing further outbreaks associated with compounded products.
-
Subjects:
-
Source:Emerg Infect Dis. 20(2):248-256.
-
Document Type:
-
Place as Subject:
-
Volume:20
-
Issue:2
-
Collection(s):
-
Main Document Checksum:urn:sha256:0ef849b160f05b2325077033c5905bce6f8bca8f7b942cc731557684b19b6b25
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases